Anti-inflammatory drugs: a hope for Alzheimer's disease? (Q34074779)

30 July 2017

1 reference

title

Anti-inflammatory drugs: a hope for Alzheimer's disease? (English)

1 reference

30 July 2017

0 references

0 references

Hüll M

1

1 reference

30 July 2017

Lieb K

series ordinal

2

1 reference

30 July 2017

Fiebich BL

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 April 2000

1 reference

Expert Opinion on Investigational Drugs

30 July 2017

published in

1 reference

30 July 2017

volume

9

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

671-683

1 reference

Amyloid, the presenilins and Alzheimer's disease

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Familial and sporadic Alzheimer's disease: neuropathology cannot exclude a final common pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

APOE genotyping and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Apolipoprotein E alleles as risk factors in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Isoform-specific interactions of apolipoprotein E with the microtubule-associated protein MAP2c: implications for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Gender-specific nonrandom association between the alpha 1-antichymotrypsin and apolipoprotein E polymorphisms in the general population and its implication for the risk of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Glial cells in Alzheimer's disease: preferential effect of APOE risk on scattered microglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

ApoE immunoreactivity and microglial cells in Alzheimer's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Frequency of stages of Alzheimer-related lesions in different age categories

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Senile plaques do not progressively accumulate with normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Amyloid beta-protein toxicity and oxidative stress in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Alzheimer's disease. Amyloid ox-tox transducers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Role of microglia in senile plaque formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Neuritic plaque evolution in Alzheimer's disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Microglial activation in early stages of amyloid beta protein deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Increased expression and subcellular translocation of the mitogen activated protein kinase kinase and mitogen-activated protein kinase in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

p38 kinase is activated in the Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Complement activation by beta-amyloid in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Topographic associations between DNA fragmentation and Alzheimer's disease neuropathology in the hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Glial cytokines in Alzheimer's disease: Review and pathogenic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

IL-6 detection in multiple sclerosis brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Alterations of glial fibrillary acidic protein mRNA level in the aging brain and in senile dementia of the Alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Site-specific hippocampal pathophysiology due to cerebral overexpression of interleukin-6 in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Reduced long-term potentiation in the dentate gyrus of transgenic mice with cerebral overexpression of interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Chronic complement C3 gene expression in the CNS of transgenic mice with astrocyte-targeted interleukin-6 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Acute phase proteins are present in amorphous plaques in the cerebral but not in the cerebellar cortex of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Up-regulated production and activation of the complement system in Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Localization and cell association of C1q in Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Aspartate residue 7 in amyloid beta-protein is critical for classical complement pathway activation: implications for Alzheimer's disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Activation of the classical complement pathway in brain tissue of Alzheimer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Ultrastructural localization of complement membrane attack complex (MAC)-like immunoreactivity in brains of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Early complement components in Alzheimer's disease brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Induction of cyclo-oxygenase 2 in brains of patients with Down's syndrome and dementia of Alzheimer type: specific localization in affected neurones and axons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Differential cellular distribution and dynamics of HSP70, cyclooxygenase-2, and c-Fos in the rat brain after transient focal ischemia or kainic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Cyclooxygenase-2 is induced globally in infarcted human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Lack of long-term effects after beta-amyloid protein injections in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Indomethacin reverses the microglial response to amyloid beta-protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: a current appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Risk of Alzheimer's disease and duration of NSAID use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

The non-steroidal anti-inflammatory drug tepoxalin inhibits interleukin-6 and alpha1-anti-chymotrypsin synthesis in astrocytes by preventing degradation of IkappaB-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Physiological and pathological roles of interleukin-6 in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Glucocorticoids in Alzheimer's disease. The story so far.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Stress-induced declarative memory impairment in healthy elderly subjects: relationship to cortisol reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Protective mechanisms of adenosine in neurons and glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Clinical trials in dementia with propentofylline

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

p38 mitogen-activated protein kinase down-regulates nitric oxide and up-regulates prostaglandin E2 biosynthesis stimulated by interleukin-1beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Interleukin-1beta-induced cyclooxygenase-2 expression requires activation of both c-Jun NH2-terminal kinase and p38 MAPK signal pathways in rat renal mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

The P38 mitogen-activated protein kinase inhibitor SB203580 antagonizes the inhibitory effects of interleukin-1beta on long-term potentiation in the rat dentate gyrus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” 11The names of the Working Group Members and the names of the Working Group Advisory Committee Members are listed in the Appendix A(section VI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Complement interactions with amyloid β1–42: A nidus for inflammation in AD brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

Neuron loss in APP transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.4.671

21 January 2018

Identifiers

DOI

10.1517/13543784.9.4.671

1 reference

30 July 2017

1 reference